Structure Therapeutics (GPCR) Return on Capital Employed Growth (1y) (2024 - 2026)
Structure Therapeutics (GPCR) Return on Capital Employed Growth (1y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 2,400.00 |
| 10 | Structure Therapeutics | 10.70 Bn | 10.70 Bn | - | 743.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 743.00 |
| Dec 31, 2025 | 251.00 |
| Sep 30, 2025 | -1,661.00 |
| Jun 30, 2025 | -935.00 |
| Mar 31, 2025 | 430.00 |
| Dec 31, 2024 | 1,374.00 |
| Sep 30, 2024 | 2,610.00 |
| Jun 30, 2024 | 1,389.00 |
| Mar 31, 2024 | 1,086.00 |